123 related articles for article (PubMed ID: 31914088)
1. Genetic variant of MAML2 in the NOTCH signaling pathway and the risk of bladder cancer: A STROBE-compliant study.
Shen Y; Lu Q; Ye H; Deng Z; Ma L; Zhang Q; Tang J; Yuan L
Medicine (Baltimore); 2020 Jan; 99(2):e18725. PubMed ID: 31914088
[TBL] [Abstract][Full Text] [Related]
2. Variants in Notch signalling pathway genes, PSEN1 and MAML2, predict overall survival in Chinese patients with epithelial ovarian cancer.
Xu Y; Cheng L; Dai H; Zhang R; Wang M; Shi T; Sun M; Cheng X; Wei Q
J Cell Mol Med; 2018 Oct; 22(10):4975-4984. PubMed ID: 30055028
[TBL] [Abstract][Full Text] [Related]
3. Effects of the MAML2 genetic variants in glioma susceptibility and prognosis.
Zhang M; Zhao Y; Zhao J; Huang T; Guo X; Ma X; Wu Y
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652449
[TBL] [Abstract][Full Text] [Related]
4. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis.
Castillejo A; Rothman N; Murta-Nascimento C; Malats N; García-Closas M; Gómez-Martínez A; Lloreta J; Tardón A; Serra C; García-Closas R; Chanock S; Silverman DT; Dosemeci M; Kogevinas M; Carrato A; Soto JL; Real FX
Int J Cancer; 2009 Feb; 124(3):608-13. PubMed ID: 19004027
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations in Hippo pathway genes influence bladder cancer risk in a Chinese population.
Huang Z; Wang X; Ma L; Guo Z; Liu H; Du M; Chu H; Wang M; Wang Z; Zhang Z
Arch Toxicol; 2020 Mar; 94(3):785-794. PubMed ID: 32123962
[TBL] [Abstract][Full Text] [Related]
6. Functional variants of RPS6KB1 and PIK3R1 in the autophagy pathway genes and risk of bladder cancer.
Ma L; Zhang D; Huang Z; Zheng R; Du M; Lv Q; Qin C; Chu H; Yuan L; Zhang Z
Arch Toxicol; 2022 Jan; 96(1):367-375. PubMed ID: 34668023
[TBL] [Abstract][Full Text] [Related]
7. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.
Srivastava P; Kapoor R; Mittal RD
Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671
[TBL] [Abstract][Full Text] [Related]
8. Endometrial vezatin and its association with endometriosis risk.
Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing related genetic variants contribute to bladder cancer risk.
Guo Z; Zhu H; Xu W; Wang X; Liu H; Wu Y; Wang M; Chu H; Zhang Z
Mol Carcinog; 2020 Aug; 59(8):923-929. PubMed ID: 32339354
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.
Shen H; Meng Y; Hu T; Li S; Du M; Xin J; Gu D; Wang M; Fu Z
Arch Toxicol; 2021 Jan; 95(1):271-281. PubMed ID: 33011827
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in NAMPT predict bladder cancer risk and prognosis in individuals from southwest Chinese Han group.
Zhang K; Zhou B; Zhang P; Zhang Z; Chen P; Pu Y; Song Y; Zhang L
Tumour Biol; 2014 May; 35(5):4031-40. PubMed ID: 24363084
[TBL] [Abstract][Full Text] [Related]
12. Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.
Gautam KA; Muktanand T; Sankhwar SN; Goel A; Sankhwar PL; Rajender S
Cytokine; 2016 Jan; 77():152-6. PubMed ID: 26605964
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.
Xing J; Dinney CP; Shete S; Huang M; Hildebrandt MA; Chen Z; Gu J
Cancer; 2012 Jan; 118(1):205-15. PubMed ID: 21692063
[TBL] [Abstract][Full Text] [Related]
14. Association between lncRNA H19 (rs217727, rs2735971 and rs3024270) polymorphisms and the risk of bladder cancer in Chinese population.
Li Z; Niu Y
Minerva Urol Nefrol; 2019 Apr; 71(2):161-167. PubMed ID: 29595036
[TBL] [Abstract][Full Text] [Related]
15. The role of oncostatin M receptor gene polymorphisms in bladder cancer.
Deng S; He SY; Zhao P; Zhang P
World J Surg Oncol; 2019 Feb; 17(1):30. PubMed ID: 30755233
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of PDCD6 polymorphisms and the susceptibility to bladder cancer.
Zhou B; Zhang P; Tang T; Zhang K; Wang Y; Song Y; Liao H; Zhang L
Tumour Biol; 2014 Aug; 35(8):7547-54. PubMed ID: 24792888
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer.
Ye Y; Yang H; Grossman HB; Dinney C; Wu X; Gu J
Cancer; 2008 Jun; 112(11):2467-74. PubMed ID: 18361427
[TBL] [Abstract][Full Text] [Related]
18. Analysis of variants in DNA damage signalling genes in bladder cancer.
Choudhury A; Elliott F; Iles MM; Churchman M; Bristow RG; Bishop DT; Kiltie AE
BMC Med Genet; 2008 Jul; 9():69. PubMed ID: 18638378
[TBL] [Abstract][Full Text] [Related]
19. Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer.
Chen M; Hildebrandt MA; Clague J; Kamat AM; Picornell A; Chang J; Zhang X; Izzo J; Yang H; Lin J; Gu J; Chanock S; Kogevinas M; Rothman N; Silverman DT; Garcia-Closas M; Grossman HB; Dinney CP; Malats N; Wu X
Cancer Prev Res (Phila); 2010 Oct; 3(10):1235-45. PubMed ID: 20858759
[TBL] [Abstract][Full Text] [Related]
20. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
Wu X; Gu J; Grossman HB; Amos CI; Etzel C; Huang M; Zhang Q; Millikan RE; Lerner S; Dinney CP; Spitz MR
Am J Hum Genet; 2006 Mar; 78(3):464-79. PubMed ID: 16465622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
